Bausch + Lomb Corporation is an eye health company operating across the United States, Canada, and multiple international markets through three business segments. The Vision Care segment manufactures contact lenses for various wearing schedules and therapeutic applications, along with lens care solutions, eye vitamins, and over-the-counter drops for conditions like dry eye and allergies. The Pharmaceuticals segment develops drugs for post-operative care, glaucoma, inflammation, and retinal diseases, while the Surgical segment produces equipment, devices, and instruments used in cataract and corneal procedures. The company distributes its products through direct sales teams and independent distributors worldwide.
1Y: 20.00 (+33.9%) · range 14.56–20.40
entry readiness 13 · NOT READY · exit proximity 35
Value area 15.32–17.47 · 5% of 120d volume overhead · clean runway
| Source | Score | Last seen |
|---|---|---|
| earnings-surprise | 0.933 | Oct 30, 2026 |
| trend-signal | 0.000 | Oct 29, 2026 |
Not yet labeled — the study prices these as positions mature.